Overview

Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, single-dose, period-balanced, three-period crossover study conducted in healthy subjects designed to evaluate whether the absorption of the FDC formulation is affected by the ingestion of a high fat meal or is altered when taken in a fasted state.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Carvedilol
Lisinopril